期刊文献+

Beclin1与p53在唾液腺多形性腺瘤和癌在唾液腺多形性腺瘤中的表达及与临床病理因素的关系研究 被引量:3

Expressions of Beclin1 and p53 in Pleomorphic Adenoma, Carcinoma in Pleomorphic Adenoma and its Relationship with Clinicopathological Factors
原文传递
导出
摘要 目的:探讨自噬体相关基因Beclin1与p53基因在唾液腺多形性腺瘤(PA)和癌在唾液腺多形性腺瘤(CPA)中的表达及其与临床病理因素的关系。方法:选择2013年1月至2017年8月于我院手术切除的PA标本45例作为PA组,CPA标本32例作为CPA组,正常腮腺组织30例作为对照组,应用免疫组化SP法对三组Belin1与p53基因表达情况进行检测,分析CPA组Beclin1、p53表达情况与临床病理因素关系及Beclin1、p53表达的相关性。结果:三组Beclin1、p53阳性表达率存在统计学差异,CPA组Beclin1阳性表达率低于PA组和对照组,CPA组和PA组p53阳性表达率高于对照组,且CPA组高于PA组(P<0.05)。CPA组Beclin1、p53表达情况与TNM分期、淋巴结转移有关,TNM分期为III-IV期患者Beclin1阳性表达率低于I-II期患者,p53阳性表达率高于I-II期患者,淋巴结转移患者Beclin1阳性表达率低于无淋巴结转移患者,p53阳性表达率高于无淋巴结转移患者,差异均有统计学意义(P<0.05),CPA组Beclin1、p53表达情况与年龄、性别、肿瘤直径、侵袭性无关(P>0.05)。经Spearman相关性分析可得,CPA患者Beclin1和p53的表达呈负相关关系(r=-0.839,P=0.000)。结论:PA及CPA中存在Beclin1异常低表达,p53异常高表达,CPA患者Beclin1、p53表达情况与TNM分期、淋巴结转移有关,且两者表达呈负相关。 Objective: To analyze the expressions of autophagic related genes Belin1 and p53 in pleomorphic adenoma(PA), carcinoma in pleomorphic adenoma(CPA) and its relationship with clinicopathological factors. Methods: 45 cases of PA excised in our hospital from January 2013 to August 2017 were selected as PA group, 32 cases of CPA specimens as CPA group, 30 normal parotid tissue as control group, the expression of Belin1 and p53 gene in three groups were detected by immunohistochemical SP method, the relationship between the expression of Beclin1 and p53 in the CPA group and the clinicopathological factors, the correlation of the expression of Beclin1 and p53 were analyzed. Results: There were statistical differences in the positive rates of Beclin1 and p53 in the three groups, the positive expression rate of Beclin1 in CPA group were lower than those in PA group and control group, the positive expression rate of p53 in CPA group were lower than those in PA group and control group, and the CPA group was higher than the PA group(P〈0.05). The ex-pression of Beclin1 and p53 in group CPA were related to TNM staging and lymph node metastasis, the positive rate of Beclin1 in TNM stage for III-IV patients was lower than that in I-II stage, the positive expression rate of p53 was higher than that in I-II stage, the positive rate of Beclin1 in patients with lymph node metastasis was lower than that of patients without lymph node metastasis, the positive expression rate of p53 was higher than that of the patients without lymph node metastasis, the differences were statistically significant(P〈0.05). The expression of Beclin1 and p53 in group CPA were not related to age, sex, tumor diameter and invasiveness(P〉0.05).Spearman correlation analysis showed that the expression of Beclin1 and p53 in CPA patients were negatively correlated(r=-0.839, P=0.000). Conclusion: The expression of Beclin1 is low abnormal and p53 is high abnormal in PA and CPA,the expression of Beclin1 and p53 in patients with CPA are related to TNM staging and lymph node metastasis, and the expression of the two is negatively correlated.
作者 曹星华 胡温庭 孙学辉 范欣 董超 栾可峰 CAO Xing-hua;HU Wen-ting;SUN Xue-hui;FAN Xin;DONG Chao;LUAN Ke-feng(Department of Stomatology,Affiliated Hospital of Weifang Medical University,Weifang,Shandong,261041,China)
出处 《现代生物医学进展》 CAS 2018年第19期3725-3728,3776,共5页 Progress in Modern Biomedicine
基金 山东省自然科学基金项目(ZR2010HL014)
关键词 唾液腺多形性腺瘤 癌在唾液腺多形性腺瘤 BECLIN1 P53 相关性 Pleomorphic adenoma Carcinoma in pleomorphic adenoma Beclinl p53 Correlation
  • 相关文献

参考文献6

二级参考文献76

  • 1向国林,朱声荣,陈卫民,陶学金,汤国雄,蔡传宝.COX-2、cyclinD_1在多形性腺瘤和癌在多形性腺瘤中的表达及意义[J].临床口腔医学杂志,2007,23(3):131-134. 被引量:7
  • 2Henriksson G, Westrin KM, Carlsoo B, et al. Recurrent primary pleomorphic adenomas of salivary gland origin: intrasurgical rupture, histopathologic features, and pseudopodia [J]. Cancer, 1998, 82(4): 617-620.
  • 3Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study [J]. Otolaryngol Head Neck Surg, 1999, 120(6): 834-840.
  • 4Stennert E, Wittekindt C, Klussmann JP, et al. Recurrent pleo- morphic adenoma of the parotid gland: a prospective histopatho-logical and immunohistochemical study [J]. Laryngoscope, 2004, 114 (1): 158-163.
  • 5Karja VJ, Syrjanen KJ, Kurvinen AK, et al. Expression and mutations of p53 in salivary gland tumours[J]. J Oral Pathol Med, 1997, 26(5): 217-223.
  • 6Nomura H, Uzawa K, Yamano Y, et al. Overexpression and altered subcellular localization of autophagy-related 16-like 1 in human oral squamous -cell carcinoma:correlation with lymphovascular invasion and lymph-node metastasis [J]. Hum Pathol, 2009, 40(1): 83-91.
  • 7Zong WX, Moll U. p53 in autophagy control[J]. Cell Cycle, 2008, 7(19): 2947.
  • 8Maiuri MC, Galluzzi L, Morselli E, et al. Autophagy regulation by p53 [J]. Curr Opin Cell Biol, 2010, 22(2): 181-185.
  • 9Tasdemir E, Chiara Maiuri M, Morselli E, et al. A dual role of p53 in the control of autophagy[J]. Autophagy,2008,4(6):810-814.
  • 10Tasdemir E, Maiuri MC, Orhon I, et al. p53 represses autophagy in a cell cycle-dependent fashion [J]. Cell Cycle, 2008, 7(19): 3006-3011.

共引文献44

同被引文献21

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部